High level expert team


                    LEWWIN PHARMplaces a strong emphasis on the independent cultivation and strategic recruitment oftop-tiertalent.The team is led by core academic leaders recognized as the National “Ten-Thousand TalentsPlan”Leading TalentandtheForeign Academicians of the Russian Academy of Engineering. Multiple key discipline leaders have been accredited as high-level talents, including National Science and Technology Leading Experts,talents under the National Major Talent Engineering Program,Foreign Academicians of the Russian Academy of Engineering, Guangdong Provincial “Pearl River Talent Plan” Leading Talent,First Batch of Guangdong Provincial Silver Age Experts, Guangdong ProvincialLeading Talent,Guangzhou Outstanding Talent,andGuangzhouLeading Talent. Furthermore, they hold prominent positions such as International GLP Experts, National GLP Experts, National Drug Evaluation Experts, and serve as Chairpersons, Vice-Chairpersons, and Secretaries-General in various national-level professional societies., thereby actively contributing to the development of the biopharmaceutical industry in the Guangdong-Hong Kong-Macao Greater Bay Area.
High quality R&D team
                    LEWWIN PHARMhas built a professional, dedicated, and one-stop non-clinical drug evaluation research team in accordance with international standards,comprising over 400 members.The discipline leaders(including study directors, quality assurance auditors, pathologists,veterinarians, etc.)in the team’s core specialized fields are all senior scientists with more than a decade of experience in pharmacology, toxicology, and GLP work, possessing extensive research expertise in drug safety evaluation, new drug pharmacodynamics, and pharmacokinetics.The team has conducted over 6,000 non-clinical drug evaluation studies, serving more than 400 pharmaceutical R&D institutions both domestically and internationally. It has established a distinctive research system and achieved significant results in key fields such as ophthalmic drugs, traditional Chinese medicine and natural products, cell and gene therapies, vaccines and anti-infectives, topical formulations, and pediatric drugs. The team has successfullycompleted multiple world-first research projects that have gained regulatory approval.